(Q42778276)

7 November 2017

A review of genome-wide transcriptomics studies in Parkinson's disease (English)

1 reference

7 November 2017

0 references

0 references

1 reference

1 reference

Soraya Seedat

3

0 references

Helena Kuivaniemi

object named as

Helena Kuivaniemi

series ordinal

4

0 references

Soraya Bardien

series ordinal

5

object named as

Soraya Bardien

1 reference

7 November 2017

Genevie Borrageiro

1

1 reference

7 November 2017

William Haylett

series ordinal

2

1 reference

7 November 2017

language of work or name

English

0 references

publication date

25 October 2017

1 reference

European Journal of Neuroscience

7 November 2017

1 reference

Involvement of endocytosis and alternative splicing in the formation of the pathological process in the early stages of Parkinson's disease.

7 November 2017

1 reference

High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease

21 January 2018

1 reference

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

21 January 2018

1 reference

Analysis of gene expression in Parkinson's disease: possible involvement of neurotrophic support and axon guidance in dopaminergic cell death

21 January 2018

1 reference

Brain transcriptomic profiling in idiopathic and LRRK2-associated Parkinson's disease.

21 January 2018

1 reference

Microarray expression analysis in idiopathic and LRRK2-associated Parkinson's disease.

21 January 2018

1 reference

Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's disease

21 January 2018

1 reference

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

Minimum information about a microarray experiment (MIAME)-toward standards for microarray data

21 January 2018

1 reference

Midbrain dopamine neurons in Parkinson's disease exhibit a dysregulated miRNA and target-gene network

21 January 2018

1 reference

Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathology

21 January 2018

1 reference

Blood transcriptomics of drug-naïve sporadic Parkinson's disease patients

21 January 2018

1 reference

Effects of gender on nigral gene expression and parkinson disease

21 January 2018

1 reference

MiRNA profile in the substantia nigra of Parkinson's disease and healthy subjects.

21 January 2018

1 reference

A network view on Parkinson's disease

21 January 2018

1 reference

Studying the system-level involvement of microRNAs in Parkinson's disease

21 January 2018

1 reference

Comparative analysis of RNA-Seq data from brain and blood samples of Parkinson's disease

21 January 2018

1 reference

Gene expression profiling in human neurodegenerative disease

21 January 2018

1 reference

Complex network-driven view of genomic mechanisms underlying Parkinson's disease: analyses in dorsal motor vagal nucleus, locus coeruleus, and substantia nigra

21 January 2018

1 reference

RNA-Seq and human complex diseases: recent accomplishments and future perspectives.

21 January 2018

1 reference

Efficient and biologically relevant consensus strategy for Parkinson's disease gene prioritization.

21 January 2018

1 reference

Parkinson's disease: mechanisms and models

21 January 2018

1 reference

Pathogenic LRRK2 mutations do not alter gene expression in cell model systems or human brain tissue

21 January 2018

1 reference

The identification of dysfunctional crosstalk of pathways in Parkinson disease.

21 January 2018

1 reference

Evidence for Immune Response, Axonal Dysfunction and Reduced Endocytosis in the Substantia Nigra in Early Stage Parkinson's Disease.

21 January 2018

1 reference

A panel of four decreased serum microRNAs as a novel biomarker for early Parkinson's disease.

21 January 2018

1 reference

Identification of therapeutic targets for Parkinson's disease via bioinformatics analysis

21 January 2018

1 reference

Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153

21 January 2018

1 reference

Transcriptome analysis reveals link between proteasomal and mitochondrial pathways in Parkinson's disease.

21 January 2018

1 reference

Gene expression profiles in Parkinson disease prefrontal cortex implicate FOXO1 and genes under its transcriptional regulation

21 January 2018

1 reference

Integrative analyses of proteomics and RNA transcriptomics implicate mitochondrial processes, protein folding pathways and GWAS loci in Parkinson disease

21 January 2018

1 reference

A Parkinson's disease gene regulatory network identifies the signaling protein RGS2 as a modulator of LRRK2 activity and neuronal toxicity

21 January 2018

1 reference

Identifying consensus disease pathways in Parkinson's disease using an integrative systems biology approach

21 January 2018

1 reference

Single-cell expression profiling of dopaminergic neurons combined with association analysis identifies pyridoxal kinase as Parkinson's disease gene

21 January 2018

1 reference

Expression analysis of dopaminergic neurons in Parkinson's disease and aging links transcriptional dysregulation of energy metabolism to cell death.

21 January 2018

1 reference

Systematic analysis of microarray datasets to identify Parkinson's disease‑associated pathways and genes

21 January 2018

1 reference

Genetic perspective on the role of the autophagy-lysosome pathway in Parkinson disease

21 January 2018

1 reference

Functional genomics reveals dysregulation of cortical olfactory receptors in Parkinson disease: novel putative chemoreceptors in the human brain.

21 January 2018

1 reference

Mitochondrial dysfunctions in Parkinson's disease

21 January 2018

1 reference

Comparative pathway and network analysis of brain transcriptome changes during adult aging and in Parkinson's disease

21 January 2018

1 reference

Current status and future directions of gene expression profiling in Parkinson's disease

21 January 2018

1 reference

Deregulation of α-synuclein in Parkinson's disease: Insight from epigenetic structure and transcriptional regulation of SNCA.

21 January 2018

1 reference

Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease

21 January 2018

1 reference

Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism.

21 January 2018

1 reference

Is Parkinson's disease a primary olfactory disorder?

21 January 2018

1 reference

Next-generation profiling to identify the molecular etiology of Parkinson dementia

21 January 2018

1 reference

microRNA Profiles in Parkinson's Disease Prefrontal Cortex

21 January 2018

1 reference

Transcriptomic Profiling of Extracellular RNAs Present in Cerebrospinal Fluid Identifies Differentially Expressed Transcripts in Parkinson's Disease

21 January 2018

1 reference

How well do we recognise non-motor symptoms in a British Parkinson's disease population?

21 January 2018

1 reference

Identification of candidate genes for Parkinson's disease through blood transcriptome analysis in LRRK2-G2019S carriers, idiopathic cases, and controls

21 January 2018

1 reference

Comparative blood transcriptome analysis in idiopathic and LRRK2 G2019S-associated Parkinson's disease

21 January 2018

1 reference

Pathway analysis of the human brain transcriptome in disease

21 January 2018

1 reference

Decreased expression of B cell related genes in leukocytes of women with Parkinson's disease

21 January 2018

1 reference

miR-126 contributes to Parkinson's disease by dysregulating the insulin-like growth factor/phosphoinositide 3-kinase signaling.

21 January 2018

1 reference

Genetics of Parkinson's disease

21 January 2018

1 reference

Epidemiology of Parkinson's disease

21 January 2018

1 reference

Apoptosis and Parkinson's disease

21 January 2018

1 reference

Polyamine pathway contributes to the pathogenesis of Parkinson disease

21 January 2018

1 reference

Monte Carlo cross-validation analysis screens pathway cross-talk associated with Parkinson's disease

21 January 2018

1 reference

Microarray analysis of transcriptome of medulla identifies potential biomarkers for Parkinson's disease

21 January 2018

1 reference

Genetics of Parkinson's disease.

21 January 2018

1 reference

Pink1 regulates the oxidative phosphorylation machinery via mitochondrial fission

21 January 2018

1 reference

Gene expression profiling predicts pathways and genes associated with Parkinson's disease

21 January 2018

1 reference

Meta-Analysis of Parkinson's Disease Transcriptome Data Using TRAM Software: Whole Substantia Nigra Tissue and Single Dopamine Neuron Differential Gene Expression.

21 January 2018

1 reference

Convergence of miRNA expression profiling, α-synuclein interacton and GWAS in Parkinson's disease

21 January 2018

1 reference

Ubiquitin proteasome system in Parkinson's disease: a keeper or a witness?

21 January 2018

1 reference

Robust dysregulation of gene expression in substantia nigra and striatum in Parkinson's disease

21 January 2018

1 reference

MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function

21 January 2018

1 reference

Upregulation of a small vault RNA (svtRNA2-1a) is an early event in Parkinson disease and induces neuronal dysfunction.

21 January 2018

1 reference

Towards a pathway definition of Parkinson's disease: a complex disorder with links to cancer, diabetes and inflammation

21 January 2018

1 reference

Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson's disease.

21 January 2018

1 reference

Transcriptional profile of Parkinson blood mononuclear cells with LRRK2 mutation

21 January 2018

1 reference

Involvement of the immune system, endocytosis and EIF2 signaling in both genetically determined and sporadic forms of Parkinson's disease

21 January 2018

1 reference

Alterations of miRNAs reveal a dysregulated molecular regulatory network in Parkinson's disease striatum.

21 January 2018

1 reference

Parkin-induced mitophagy in the pathogenesis of Parkinson disease

21 January 2018

1 reference

Mitochondrial abnormalities in the putamen in Parkinson's disease dyskinesia

21 January 2018

1 reference

RNA-binding disturbances as a continuum from spinocerebellar ataxia type 2 to Parkinson disease

21 January 2018

1 reference

Multiregional gene expression profiling identifies MRPS6 as a possible candidate gene for Parkinson's disease.

21 January 2018

1 reference

Synaptic dysfunction in Parkinson's disease.

21 January 2018

1 reference

Gene Expression Differences in Peripheral Blood of Parkinson's Disease Patients with Distinct Progression Profiles

21 January 2018

1 reference

Looking beyond the brain to improve the pathogenic understanding of Parkinson's disease: implications of whole transcriptome profiling of Patients' skin.

21 January 2018

1 reference

Biosignatures for Parkinson's disease and atypical parkinsonian disorders patients

21 January 2018

1 reference

Construction and analysis of the protein-protein interaction networks based on gene expression profiles of Parkinson's disease

21 January 2018

1 reference

Systems-based analyses of brain regions functionally impacted in Parkinson's disease reveals underlying causal mechanisms

21 January 2018

1 reference

Network-based metaanalysis identifies HNF4A and PTBP1 as longitudinally dynamic biomarkers for Parkinson's disease

21 January 2018

1 reference

Mitochondrial complex I deficiency in Parkinson's disease

21 January 2018

1 reference

Molecular markers of early Parkinson's disease based on gene expression in blood

21 January 2018

1 reference

SRRM2, a potential blood biomarker revealing high alternative splicing in Parkinson's disease

21 January 2018

1 reference

Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation.

21 January 2018

1 reference

Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology

21 January 2018

1 reference

Evidence for gender-specific transcriptional profiles of nigral dopamine neurons in Parkinson disease

21 January 2018

1 reference

Advanced microarray analysis highlights modified neuro-immune signaling in nucleated blood cells from Parkinson's disease patients

21 January 2018

1 reference

Deep brain stimulation induces rapidly reversible transcript changes in Parkinson's leucocytes

21 January 2018

1 reference

Exon arrays reveal alternative splicing aberrations in Parkinson's disease leukocytes

21 January 2018

1 reference

Deep brain stimulation modulates nonsense-mediated RNA decay in Parkinson's patients leukocytes

21 January 2018

1 reference

Small RNA sequencing-microarray analyses in Parkinson leukocytes reveal deep brain stimulation-induced splicing changes that classify brain region transcriptomes

21 January 2018

1 reference

Long non-coding RNA and alternative splicing modulations in Parkinson's leukocytes identified by RNA sequencing

21 January 2018

1 reference

Genetic susceptibility variants in parkinsonism

21 January 2018

1 reference

Alpha-synuclein in Lewy bodies

21 January 2018

1 reference

Neuronal gene expression correlates of Parkinson's disease with dementia

21 January 2018

1 reference

Identification of potential drugs for Parkinson's disease based on a sub-pathway method

21 January 2018

1 reference

A cross-study transcriptional analysis of Parkinson's disease

21 January 2018

1 reference

RNA-Seq analysis to capture the transcriptome landscape of a single cell

21 January 2018

1 reference

Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and Multiple System Atrophy.

21 January 2018

1 reference

miRNAs as biomarkers of neurodegenerative disorders

21 January 2018

1 reference

Transcriptional changes in multiple system atrophy and Parkinson's disease putamen

21 January 2018

1 reference

Novel microRNA discovery using small RNA sequencing in post-mortem human brain.

21 January 2018

1 reference

Neuroinflammation in Parkinson's disease and its potential as therapeutic target

21 January 2018

1 reference

Meta-Analysis of Parkinson's Disease and Alzheimer's Disease Revealed Commonly Impaired Pathways and Dysregulation of NRF2-Dependent Genes.

21 January 2018

1 reference

Progression of motor symptoms in Parkinson's disease

21 January 2018

1 reference

Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms.

21 January 2018

1 reference

Identification of key pathways and transcription factors related to Parkinson disease in genome wide

21 January 2018

1 reference

PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease

21 January 2018

1 reference

Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/EJN.13760

1 reference

release_v4nke52ryngo3ke6wengtuk52a

7 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/v4nke52ryngo3ke6wengtuk52a

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference